Hepatitis B and inflammatory bowel disease: Role of antiviral prophylaxis

doi:10.3748/wjg.v19.i9.1342

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5437)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

528

HTML

4669

Figures (1-1)

134

Tables (1-1)

106

Sum=5437

Mar 7, 2013 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Mar 7, 2013; 19(9): 1342-1348
Published online Mar 7, 2013. doi: 10.3748/wjg.v19.i9.1342

Open in New Tab Full Size Figure Download Figure

Figure 1 An algorithm for the management of patient with inflammatory bowel disease with different hepatitis B virus infection status. NAs: Nucleos(t)ide analogues; IBD: Inflammatory bowel disease; HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; HBsAb: Hepatitis B surface antibody; HBcAb: Hepatitis B core antibody.

Citation: López-Serrano P, Pérez-Calle JL, Sánchez-Tembleque MD. Hepatitis B and inflammatory bowel disease: Role of antiviral prophylaxis. World J Gastroenterol 2013; 19(9): 1342-1348
URL: https://www.wjgnet.com/1007-9327/full/v19/i9/1342.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i9.1342